Research interests
Clinical and imaging factors associated with disease progression and recovery in infiltrative cardiomyopathies[9]
JM
Jennifer Maning
As of 2025 · Last known relationship
As of 2025 · Last known relationship
Jennifer Maning, DO, is a physician leader in cardiac amyloidosis and advanced heart failure care. She is identified as Director of the Cardiac Amyloidosis Program at the University of Miami Health System, with clinical interests spanning advanced heart failure, heart transplantation, mechanical circulatory support, and infiltrative cardiomyopathies. Her research interests include earlier detection and treatment of cardiac amyloidosis, translating novel therapies into practice, studying disease progression, and developing coordinated care models. She completed internal medicine residency at University of Miami/Jackson Memorial Hospital in 2021 and cardiovascular disease and advanced heart failure and transplant fellowships at Northwestern University Feinberg School of Medicine in 2024 and 2025. She was Chief Cardiovascular Fellow from July 2022 to June 2023 and contributed as a FIT editor for the Journal of Cardiac Failure.
Each topic is linked to its supporting source in Sources.
Training includes Presentation titled “Updates in the Management of Cardiac Amyloid” at Miami Valves 2025, Advanced Heart Failure & Transplant Cardiology Fellowship at Northwestern University Feinberg School of Medicine, Cardiovascular Disease Fellowship at Northwestern University Feinberg School of Medicine, and Chief Cardiovascular Fellow, plus 7 more records.
Explore education and trainingAs of 2025
As of 2025
2024
As of 2024
As of 2023
2022
As of 2021
As of 2018
Clinical and imaging factors associated with disease progression and recovery in infiltrative cardiomyopathies[9]
Coordinated care models to improve outcomes in advanced heart failure and infiltrative cardiomyopathies[9]
Early detection and treatment strategies for cardiac amyloidosis[9]
Professional interest in driving innovation in clinical trials[10]
Translational strategies to bridge novel therapies into clinical practice[9]